
Company valuation, historical trends, and peer comparisons.
According to Cambium Bio Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 9.63M. This represents a change of -3.94% compared to the average of 10.02M of the last 4 quarters.
The mean historical Enterprise Value of Cambium Bio Limited over the last ten years is 1.72M. The current 9.63M Enterprise Value has changed 459.32% with respect to the historical average. Over the past ten years (40 quarters), CMB.AX's Enterprise Value was at its highest in in the September 2025 quarter at 10.60M. The Enterprise Value was at its lowest in in the June 2017 quarter at -3280314.00.
Average
1.72M
Median
1.67M
Minimum
-3280314.00
Maximum
9.31M
Discovering the peaks and valleys of Cambium Bio Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 124.05%
Maximum Annual Enterprise Value = 9.31M
Minimum Annual Increase = -1949.73%
Minimum Annual Enterprise Value = -3280314.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 9.31M | 124.05% |
| 2025 | 4.16M | -670.67% |
| 2024 | -728204.40 | -125.35% |
| 2023 | 2.87M | 34.49% |
| 2022 | 2.14M | -182.35% |
| 2021 | -2593478.40 | -316.01% |
| 2020 | 1.20M | -72.58% |
| 2019 | 4.38M | -1949.73% |
| 2018 | -236757.00 | -92.78% |
| 2017 | -3280314.00 | -1300.05% |
The current Enterprise Value of Cambium Bio Limited (CMB.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.25M
5-year avg
3.55M
10-year avg
1.72M
Cambium Bio Limited’s Enterprise Value is greater than Cazaly Resources Limited (5.22M), greater than Chimeric Therapeutics Limited (2.83K), less than Caspin Resources Limited (21.34M), less than Cavalier Resources Limited (16.80M), greater than Immutep Limited (-36877371.00), less than Kura Oncology, Inc. (631.20M), less than Olema Pharmaceuticals, Inc. (611.79M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.22M | $8.84M | |
| 2.83K | $123.13K | |
| 21.34M | $28.31M | |
| 16.80M | $20.49M | |
| -36877371.00 | $30.95M | |
| 631.20M | $676.99M | |
| 611.79M | $659.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cambium Bio Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cambium Bio Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cambium Bio Limited's Enterprise Value?
What is the highest Enterprise Value for Cambium Bio Limited (CMB.AX)?
What is the 3-year average Enterprise Value for Cambium Bio Limited (CMB.AX)?
What is the 5-year average Enterprise Value for Cambium Bio Limited (CMB.AX)?
How does the current Enterprise Value for Cambium Bio Limited (CMB.AX) compare to its historical average?